Overview
Fluidic Sciences offers in-solution technologies for protein interaction analysis, including the Fluidity One-M instrument using Microfluidic Diffusional Sizing (MDS) to measure binding affinity, stoichiometry, size, and concentration without immobilization in complex matrices like serum and plasma. Following its acquisition of Sphere Bio's assets in September 2025, the company provides an integrated portfolio of picodroplet microfluidic platforms, consumables, and reagents for high-throughput single-cell screening, isolation, and biologics discovery. These solutions support biotherapeutic development, cell engineering, and synthetic biology workflows.
Frequently asked questions
- What are Fluidic Sciences' key technologies for protein analysis?
- The Fluidity One-M instrument uses Microfluidic Diffusional Sizing (MDS) for immobilization-free measurement of binding affinity (Kd), stoichiometry, size, and concentration directly in solution, including complex backgrounds like serum, plasma, and lysate.
- What capabilities does Fluidic Sciences offer for single-cell analysis?
- Through the acquired Sphere Bio assets, Fluidic Sciences provides picodroplet systems and the Cyto-Mine Chroma platform for high-throughput single-cell screening, isolation, monoclonality assurance, and integration with protein interaction workflows.
- What applications do Fluidic Sciences' platforms support?
- Platforms support biologics discovery and development, cell engineering, synthetic biology, and biotherapeutic research by enabling end-to-end workflows from single-cell function to molecular binding analysis.